eCAM Advance Access published online on February 9, 2005
eCAM, doi:10.1093/ecam/neh060
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Botany, Institute of Biosciences, University of São Paulo, São Paulo, SP, Brazil
* To whom correspondence should be addressed. Propolis is a hive product containing chiefly beeswax and plant-derived substances such as resin and volatile compounds. Propolis has been used as an antiseptic and wound healer since ancient times and interest for the product has increased recently. Probably few plant species contribute as major resin sources. Green propolis derives mainly from vegetative apices of Baccharis dracunculifolia (alecrim plants). However, wide variation detected in the chemical composition suggests contributions from alternative resin plant sources. Predominant components of the resin of green propolis are cinnamic acids, chiefly compounds bearing prenyl groups. Terpenoid compounds, such as sesqui, di and pentacyclic triterpenoids, have been detected in many, but not all, samples investigated. Propolis research has uncovered potentialities of substances previously isolated from plants and has detected constituents of plant origin that would hardly be known otherwise.
Received October 1, 2004
Accepted January 10, 2005
Original Article
Origin and Chemical Variation of Brazilian Propolis
2 APTA (Agência Paulista de Tecnologia dos Agronegócios)/SAA-SP, Pindamonhangaba, SP, Brazil
3 Viçosa Federal University, Department of Animal Biology, Viçosa, MG, Brazil
Antonio Salatino, E-mail: asalatin{at}ib.usp.br
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Salomao, P. R. S. Pereira, L. C. Campos, C. M. Borba, P. H. Cabello, M. C. Marcucci, and S. L. de Castro Brazilian Propolis: Correlation Between Chemical Composition and Antimicrobial Activity Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 317 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Senedese, A. R. Rodrigues, M. A. Furtado, V. D. Faustino, A. A. Berretta, J. M. Marchetti, and D. C. Tavares Assessment of the Mutagenic Activity of Extracts of Brazilian Propolis in Topical Pharmaceutical Formulations on Mammalian Cells In Vitro and In Vivo Evid. Based Complement. Altern. Med., July 9, 2008; (2008) nen049v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Teixeira, D. Message, G. Negri, A. Salatino, and P. C. Stringheta Seasonal Variation, Chemical Composition and Antioxidant activity of Brazilian Propolis Samples Evid. Based Complement. Altern. Med., January 31, 2008; (2008) nem177v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Cooper Colony Collapse Disorder May Affect Complementary and Alternative Medicine Evid. Based Complement. Altern. Med., September 1, 2007; 4(3): 275 - 277. [Full Text] [PDF] |
||||
![]() |
S. P. Leite, J. R. C. Vieira, P. L. de Medeiros, R. M. P. Leite, V. L. de Menezes Lima, H. S. Xavier, and E. de Oliveira Lima Antimicrobial Activity of Indigofera suffruticosa Evid. Based Complement. Altern. Med., June 1, 2006; 3(2): 261 - 265. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Trusheva, M. Popova, V. Bankova, S. Simova, M. C. Marcucci, P. L. Miorin, F. d. R. Pasin, and I. Tsvetkova Bioactive Constituents of Brazilian Red Propolis Evid. Based Complement. Altern. Med., June 1, 2006; 3(2): 249 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Cooper eCAM benefits from diversity that derives from CAM Evid. Based Complement. Altern. Med., September 1, 2005; 2(3): 263 - 265. [Full Text] [PDF] |
||||
